The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

M. O. Holmstrom, E. Martinenaite, S. M. Ahmad, O. Met, C. Friese, L. Kjaer, C. H. Riley, P. thor Straten, I. M. Svane, H. C. Hasselbalch, M. H. Andersen

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology